PR97361

HSINCHU, Aug. 8, 2022 /PRNewswire=KYODO JBN/ --

NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval

from the local government of the Ministry of Health and Welfare in Taiwan in

July 2022 and is planned for submission to the FDA (U.S. Food and Drug

Administration) for clearance by the end of 2022.

The NaoTrac human trials were performed at the reputable Hualien Tzu-Chi

Medical Center, with the External Ventricular Drain (EVD) placement abstract

results published in the well-known European journal Acta Neurochirurgica. Dr.

Tsung-Lang, Chiu stated, "The results of this report show that the average time

spent on the patient registration was 1423.8 seconds. The mean target deviation

was 1.68mm, and the mean angular deviation was 1.99 degrees, all within the

accepted tolerance for minimal tissue damage." Dr. Chiu concluded, "NaoTrac has

several advantages besides the high precision, like a non-invasive, non-contact

patient registration process with a fast and accurate procedure, the system

provides precise navigation to the surgical target. It's also user-friendly,

and has many other benefits."

NaoTrac's technology, Surface Mapping Auto-Registration Technology (SMART),

merges machine vision, robotics, and A.I. to streamline surgical procedures

with real-time imaging and minimal invasive outcomes. NaoTrac will be used for

other surgeries like endoscopic brain surgery, cell implantation, and other

operations. Brain Navi is attending the CNS Annual Meeting held in San

Francisco, and the Taiwan Expo USA 2022 in Washington D.C., both in October, to

showcase NaoTrac and the release of the neurosurgical endoscope.

About Brain Navi

Brain Navi Biotechnology is a leading Taiwanese surgical robotic company. We

design and develop innovative navigation and robotic surgery technologies for

surgeons to improve surgical accuracy. Brain Navi's exclusive Surface Mapping

Auto-registration Technology (SMART) is a significant surgical robotic

breakthrough that merges machine vision, robotics, and AI technology to achieve

streamlined surgical procedures with real-time imaging and minimal invasive

outcomes.

Source Brain Navi Biotechnology Co., Ltd.

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=427098

   Caption: Taiwan approves the First Autonomous Neurosurgical Navigation Robot, NaoTrac,

from Brain Navi Biotechnology